CureVac NV (CVAC)
4.66
0.00 (0.00%)
USD |
NASDAQ |
Feb 20, 16:00
CureVac SG&A Expense (Quarterly) : 29.72M for Sept. 30, 2025
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| BioNTech SE | 173.54M |
| Bayer AG | 3.979B |
| MediGene AG | -- |
| InflaRx NV | 4.427M |
| Immatics NV | 14.81M |